Abstract
Treatment with interferon-beta (IFN-beta) increases B-cell activating factor of the TNF family (BAFF) expression in multiple sclerosis (MS), raising the concern that treatment of MS patients with IFN-beta may activate autoimmune B cells and stimulate the production of MS-associated autoantibodies.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Multiple Sclerosis |
Vol/bind | 17 |
Udgave nummer | 5 |
Sider (fra-til) | 567-77 |
Antal sider | 11 |
ISSN | 1352-4585 |
DOI | |
Status | Udgivet - 1 maj 2011 |